Therapeutic efficacy of vesicular stomatitis virus-based E6 vaccination in rabbits (Q44251810)

1 December 2017

Therapeutic efficacy of vesicular stomatitis virus-based E6 vaccination in rabbits (English)

1 reference

1 December 2017

1 reference

4

Anjeanette Roberts

1 reference

1 December 2017

Janet L Brandsma

1

1 reference

1 December 2017

Mark Shlyankevich

2

1 reference

1 December 2017

Linda Buonocore

3

1 reference

1 December 2017

Steven M Becker

5

1 reference

1 December 2017

John K Rose

6

1 reference

1 December 2017

language of work or name

English

0 references

publication date

22 August 2006

1 reference

1 December 2017

12

1 reference

inferred from page(s)

published in

Vaccine

1 reference

1 December 2017

25

1 reference

1 December 2017

4

1 reference

1 December 2017

751-762

1 reference

The prevalence of common skin conditions in Australian school students: 1. Common, plane and plantar viral warts

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

Human papillomavirus infections in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

Epidemiology of Genital Human Papillomavirus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

Human papillomavirus and skin cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

Immunology of the human papilloma virus in relation to cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

Ubiquitin-fused and/or multiple early genes from cottontail rabbit papillomavirus as DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

Granulocyte-macrophage colony-stimulating factor priming plus papillomavirus E6 DNA vaccination: effects on papilloma formation and regression in the cottontail rabbit papillomavirus--rabbit model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

Intracutaneous vaccination of rabbits with the E6 gene of cottontail rabbit papillomavirus provides partial protection against virus challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

Replication-competent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

Intranasal vaccination with a recombinant vesicular stomatitis virus expressing cottontail rabbit papillomavirus L1 protein provides complete protection against papillomavirus-induced disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

Complete protection from papillomavirus challenge after a single vaccination with a vesicular stomatitis virus vector expressing high levels of L1 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

Robust recall and long-term memory T-cell responses induced by prime-boost regimens with heterologous live viral vectors expressing human immunodeficiency virus type 1 Gag and Env proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

Cellular immunity in cutaneous and genital HPV infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

Recombinant vesicular stomatitis viruses from DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

Optimization of cottontail rabbit papilloma virus challenge technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

Vaccination of rabbits with an adenovirus vector expressing the papillomavirus E2 protein leads to clearance of papillomas and infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

Intracutaneous vaccination of rabbits with the cottontail rabbit papillomavirus (CRPV) L1 gene protects against virus challenge .

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

OBSERVATIONS ON THE RELATION OF THE VIRUS CAUSING RABBIT PAPILLOMAS TO THE CANCERS DERIVING THEREFROM : I. THE INFLUENCE OF THE HOST SPECIES AND OF THE PATHOGENIC ACTIVITY AND CONCENTRATION OF THE VIRUS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

Induction of MHC class I-restricted CTL response by DNA immunization with ubiquitin-influenza virus nucleoprotein fusion antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

Targeting of hepatitis C virus core protein for MHC I or MHC II presentation does not enhance induction of immune responses to DNA vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

Intramuscular injection of plasmid DNA encoding cottontail rabbit papillomavirus E1, E2, E6 and E7 induces T cell-mediated but not humoral immune responses in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

The rabbit viral skin papillomas and carcinomas: a model for the immunogenetics of HPV-associated carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

DNA vaccination prevents and/or delays carcinoma development of papillomavirus-induced skin papillomas on rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

Characterization of nonpathogenic, live, viral vaccine vectors inducing potent cellular immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

A single-cycle vaccine vector based on vesicular stomatitis virus can induce immune responses comparable to those generated by a replication-competent vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

7 January 2021

Papillomavirus E7 protein binding to the retinoblastoma protein is not required for viral induction of warts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

7 January 2021

DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

7 January 2021

The Shope papilloma-carcinoma complex of rabbits: a model system of neoplastic progression and spontaneous regression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.012

7 January 2021

10.1016/J.VACCINE.2006.08.012

Identifiers

DOI

1 reference

1 December 2017

1 reference